Seminar - Glucagon-like peptide 1 quantitation: on the speed and sensitivity of Gyrolab® biomarker assays

  1. Home

  2. caret-right icon

    Immunoassay Solutions

  3. caret-right icon

    Resources

  4. caret-right icon

    Seminar - Glucagon-like peptide 1 quantification

Speaker: Mark Dysinger

Mark Dysinger, Senior Scientist, Pharmacokinetics, Dynamics, and Metabolism, Pfizer Global Research and Development, presented Glucagon-Like Peptide 1 (GLP-1) Quantitation: Gyrolab vs Other Detection Platforms at the 2nd Annual North American Gyrolab Seminar.

The Gyrolab assay reduced turnaround time considerably compared to assays based on ELISA and MSD technology with:

  • 3 × faster assay development
  • 3 × shorter assay run time
View Seminar